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Abstract— Tuberculosis (TB) is among top ten causes of deaths worldwide. It is the single most cause of deaths by an infectious 
disease and is ranked 2nd only after the HIV/AIDS. In third world countries, the diagnosis of TB is done through conventional 
methods. To diagnostic results are obtain from conventional methods such as blood, culture, sputum and biopsies. They are tedious as 
well as take long time like 1-2 weeks or maybe evenmore. Therefore, to lower the detection time and raise the accuracy of diagnosis 
several researches have been carried out. In the past fifty years, due to the advanced and sophisticated technologies, in medical as well 
as computer science fields, have paved a way to utilize the essence of both the areas. In Artificial Intelligence (AI) various Machine 
Learning (ML) algorithms have furthered the interests in Computer-aided Detection (CADe) and Diagnosis (CADx) methods. These 
methodologies assist in medical field for diagnosing the diseases through clinical signs and symptoms as well as radiological images of 
the patient. They have been implemented for the diagnosis of TB. Advances in AI algorithms, has unveiled great promises in 
identifying the presence and absence of TB.  As of late, many attempts have been made to formulate the strategies to increase the 
classification accuracy of TB diagnosis using the AI and machine learning approach. This review paper, aims to describes the diverse 
AI approaches employed in the diagnosis of TB. 
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I. NTRODUCTION 
Tuberculosis is an age-old disease. This ancient killer 
disease has survived for thousands of years. There are quite 
a few archaeological evidences, found in ancient Egypt, 
pointing to the existence of this disease. Such as pott’s 
disease (spinal tuberculosis), found in Egyptian mummies 
[1],[2] . Furthermore, several literary documentations reveal 
the existence of TB, in ancient India, China and Greece [3], 
[4]. TB was known by various names, throughout the history. 
In ancient Greece, it was called “Phthisis” or “consumption” 
(because of extreme weight loss in patients). During middle 
ages, scrofula (Mycobacterial cervical lymphadenitis) was 
popularly believed, to be cured by the royal touch of Kings 
of England and France. It was known as “King’s evil”. Later 
in the 18th century, prevalence of TB was so high, that one in 
every fourth death was attributed to TB [5]. The term “White 
plague” was used to describe TB patients, because of 
inadequate ventilation, overcrowding, malnutrition and 
accommodation facilities in TB sanatoriums [6].   
 Robert Koch in 1822, discovered Mycobacterium 
Tuberculosis, the causative organism of TB [7]. He 
demonstrated that, due to high lipid content in the cellular 
wall of the micro-organism, it was difficult to identify using 
common dyes [8]. The discovery of Bacillus-Chalmette 
Guerin (BCG) in 1908 [9] and anti-tuberculosis drugs in 
1943 gave hope for the elimination of TB disease[10]. Since, 
the discoveries of vaccines, there was a significant decrease 
in the TB cases. In 1990s, due to the onset of AIDS 
pandemic, TB cases rose again drastically with TB resistant 
strains[11]–[24]. Subsequently, many strategies were 
developed for the control and prevention of the TB disease. 
To commemorate the discovery made by Koch, every year 
24th March is recognized as “World TB day”. TB is still one 
of the leading cause of deaths in the world. According to 
World Health Organization (WHO) in 2015, TB was 
detected in 10.4 million people out of which 1.8 million 
people succumbed to death from the TB illness [25].  
A. Types of TB  
TB is an airborne infectious disease. It is caused by 
bacteria Mycobacterium Tuberculosis (MTB). TB is 
categorized into two main types, depending on the site which 
MTB affects. If the bacteria affect lungs and its surrounding 
regions, then it is called as Pulmonary Tuberculosis (PTB). 
When the bacteria affects and spreads to other parts of the 
body then it is called Extra Pulmonary Tuberculosis (EPTB). 
Few types of PTB are primary Tuberculosis pneumonia, 
cavity Tuberculosis, Tuberculosis pleurisy, military TB and 
laryngeal TB. On the other hand, types of EPTB include 
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Pot’s disease, lymph node disease, Tuberculosis meningitis, 
adrenal Tuberculosis, Tuberculosis peritonitis, Tuberculosis 
pericarditis, Osteal tuberculosis [26]–[30]. The symptoms of 
TB and few types of PTB and EPTB are shown in Fig. 1
.  
  
 
 
Fig. 1 Types of PTB and EPTB [31] 
.
B. Co-infection, risk factors and other causes of TB 
TB is a common cause of AIDS-defining diseases. It is 
also a leading cause of deaths in AIDS patients [32]. TB and 
Diabetes Mellitus (DM) is another common co-infection, the 
risk of getting TB is higher in patients with diabetes [33]–
[39], as the immunity of a diabetes patient is less when 
compared to a reasonable person [40]. The other risk factors 
that cause TB are smoking, silicosis, crowding, prisons, 
substance abuse, alcoholism, end-stage renal diseases and 
malnutrition [41]–[46],[32].   
C. The conventional method of diagnosing TB 
The bacterium generally spreads through the air, when a 
person having TB coughs, sneezes or talks. Air is the major 
medium for the spreading of MTB. At times TB can spread 
through Cattle, Monkey’s, Sheep’s, Goat’s, Cat’s and Dog’s 
[47]. The bacteria typically affects the lungs, and in a few 
cases, it might also affect the brain, spine, and kidney [48]. 
There are two conditions of TB-which are Active 
Tuberculosis (TB) and Latent Tuberculosis (LTB). Active 
TB is one where the TB bacteria are active and multiplying 
in the body. The people having active TB show symptoms of 
persisting cough for more than two weeks, followed by pain 
in the chest, loss of appetite, loss of weight, weakness, 
fatigue, chills, fever, and sweating at night.  The diagnosis of 
the active TB is done either by skin test, blood test, chest X-
ray, positive sputum smear culture or combining these tests. 
In latent TB, the person infected may not show signs and 
symptoms as in active TB. LTB can stay dormant for many 
years and may become active when the person’s immunity 
goes down. LTB cannot spread to others; it is usually 
diagnosed when a person tests positive for TB skin test or 
TB blood test [48]. Table 1 gives a brief description of the 
current TB tests, their inference and shortcomings [49]. 
D.  Artificial Intelligence in Medicine (AIM) 
The term “Artificial Intelligence” (AI) was coined by John 
McCarthy [50]. The word “AI,” was used for the first time in 
a workshop organized by McCarty, at Dartmouth College 
[51]. The workshop included M.L Minsky, N Rochester 
(IBM), C.E Shannon (Known as “the father of information 
theory”) and other scholars, who were in future to become 
prominent figures, in the field of AI [52]. Over the last 60 
years, the field of AI has been through many ups and downs. 
M.L Minsky and S.A Papert published a book named 
“Perceptrons,” which describes limitations of two-input 
perceptron’s. Many consider this book to mark the beginning 
of “AI winter.” An era where the funding for AI projects 
declined drastically [51], [53]. Nevertheless, the field of AI 
continued with significant progress under a different name 
called Intelligent Knowledge-Based Systems (IKBS).  
In 1975, MYCIN was the first, AI expert system (also 
known as knowledge-based systems), to provide 
consultation and diagnosis for Antimicrobial therapy. 
Edward Shortleaf developed it for his Ph.D. dissertation [54]. 
The other early expert systems were PIP- Present Illness 
Program (acquires the diagnosis of patients with renal 
disease ), INTERNIST-1- internal medicine diagnosis by 
modeling behavior of clinicians[55], CASNET (Casual 
Associated Network)- for Glaucoma assessment and therapy, 
PUFF- Pulmonary function test interpretation[56-58]. Miller 
[59] has done a review on medical expert systems from 1954 
to 1993. Shu-Hsien Liao [60], has conducted a review on 
expert systems from 1995 to 2004. Reference [60] has 
covered all expert system of one decade, including medical 
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expert systems. In recent years, there has been a huge 
advancement in the health care system. The technology has 
paved a way, for the patients to get an instant diagnosis 
about their vital health through health apps and wearable 
[61]. The generated report is maintained in Electronic Health 
Records. (EHRs) and alerts the doctor about any abnormal 
condition of the patient. 
 
TABLE  I  
MAIN SHORTCOMINGS OF TB DIAGNOSTIC TESTS [49]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II. MATERIAL AND METHOD  
In this section, an overview of various AI methodologies, 
applied in the diagnosis of TB is presented. Several studies 
have been carried out for the diagnosis of TB implementing 
AI algorithms. El-Solh et al., [62] claimed that they were the 
first to implement an AI technique for diagnosing TB. Later, 
many different approaches were utilized to achieve 
maximum accuracy to diagnose TB. AI uses predictive 
algorithms such as Decision Trees, Support Vector Machine 
(SVM), Naive Bayes Classifier, Genetic Algorithms (GAs), 
and Fuzzy Algorithms (FA).  
A. A ubiquitous method in medical diagnosis using AI 
AI is an area of computer science. It helps in the 
development of computers that, can mimic the human-like 
thought processing, reasoning and self-correction ability 
[63]. A rule of thumb has always been followed since AI 
techniques were applied in diagnosing diseases. The creation 
of a specific disease database is done by collecting a 
patient’s medical report or Electronic Health Record 
(EHRs)[64]-[65]. Amato et al.,[66] generalized a few steps 
involved in the process of diagnosing medical data using 
ANNs. The essential steps are shown in Figure 2.  
Steps are shown in Fig. 2, refer to the training phase (the 
green color background). This model is acclimatized to 
recognize the symptoms of the disease. The next stage 
involves the testing phase (Diagnosis), wherein new records 
of the patients will be tested against the verified database. 
The outcome of the diagnosis may be positive, negative or 
uncertain. This is verified by the doctor as shown in Fig. 2 
(blue color background). Based on the prediction accuracy, 
if the data diagnosed is correct, it is later shifted to training 
dataset. 
 
 
 
Fig. 2 ANNs -based medical diagnosis[66]. 
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B. Data mining approaches  
Rusdah et al.,[67] discussed exclusively on the different 
data mining approaches implemented for the diagnosis of the 
TB. The raw data before using for diagnosis must go through 
the data mining process [67]–[69]. Data mining process 
involves the pre-processing of the data. Such as data 
cleaning, data transformation, data integration, and data 
reduction. In their research, the authors have attempted to 
classify the PTB and EPTB. In their research, they 
considered only the physical symptoms of the disease, i.e., 
duration of a cough, Loss of Appetite, Weight Loss, 
Hemoptysis (blood in the sputum),  and so on. In the 
preliminary stage of the disease, these symptoms are 
common in both the cases of PTB and EPTB. Hence, they 
could not differentiate between PTB and EPTB. Therefore, 
they discarded all EPTB cases and investigated only PTB 
cases using ensemble methods on four classifiers. They 
obtained high accuracy with SVM classifier.   
Dongardive et al.,[70] utilized classification technique 
named Identification tree (IDT) to computationally diagnose 
TB[71]. IDT uses the Average Disorder Score (ADS) and 
picks the most significant parameter. At first 45 parameters 
were included in the study, which was later reduced to 19 
parameters. The IDT generated a list of 12 rules for TB 
diagnosis. The accuracy obtained using IDT is 94.50%.    
C. Neural Network with Multilayers 
A neural network is a computational model which is 
similar to the human brain. It consists of several 
interconnected nodes (neurons), which processes the given 
information with its self-learning ability and generates better 
results[72]. Figure 3 shows, a simple neural network with 
one “input layer,” two “hidden layer” and an “output layer.” 
Every single layer has neurons, which are connected by 
weighted connections. The i-th neuron in one layer and j-th 
neuron in the next layer determine the value of Wij[66].  
El-Solh et al.,[62] implemented a General Regression 
Neural Network (GRNN) algorithm[73], for predicting 
active pulmonary tuberculosis. The Input pattern was created 
by using 21 unique parameters. These parameters were 
differentiated into three main categories viz, demographic, 
constitutional symptoms, and radiographic findings. The 
neurons required to form the hidden layer is decided by the 
number of patterns used while training the dataset. GRNNs 
requires one neuron per pattern processed. For the 
assessment of the model, they applied the 10-fold cross-
validation method. The diagnosis accuracy of the model was 
reported to be 92.30% accurate[62]. 
 
 
Fig. 3 A simple structure neural network [66]. 
Santos et al.,[74] utilized ANNs for developing and 
evaluating a prediction model for the diagnosis of Smear 
Negative Pulmonary Tuberculosis (SNPT). The authors 
considered only symptoms and physical signs for designing 
the neural network. The neural network was implemented 
using multilayer feedforward method architecture with Back 
Propagation (BP) algorithm and single hidden layer. The 
authors reported a 77% accuracy of the model [74].  
Er, et al.,[75] in their study choose thirty-eight features to 
form the patient’s medical reports. They used GRNN and BP 
algorithms and compared with the previous studies on 
GRNN [62] and BP [74]. They achieved an accuracy of 
93.18% compared to 92.30% by [62].  In the case of  MLNN 
with BP (single hidden layer)  This study[75], achieved an 
accuracy of 93.04% relatively higher and more accurate 
than[74] who reported 77% accuracy. The authors, used a 
similar structure and same training algorithm as reported 
by[62] and [74], but the input features selected for 
diagnosing the tuberculosis disease were much better and 
may have resulted in higher accuracy.  
Furthermore, Er et al. also implemented two different 
Multilayer Neural Networks (MLNNs) model structures. 
Levenberg-Marquardt (LM) [76], [77] and Back-Propagation 
with Momentum (BPwM) algorithm [78] approaches were 
used for training MLNNs. The LM and BPwM algorithms 
were implemented on the first model having a single hidden 
layer and on the second model having two hidden layers. To 
calculate the performance of their neural network, they used 
a 3-fold cross-validation method. In this study, 95.08% of 
classification accuracy was received by the LM algorithm 
using two hidden layers. The authors claimed that the LM 
training algorithm converged better than BPwM training 
algorithm and MLNNs using two hidden layers performed 
better than those using a single hidden layer.   
Er, et al.,[79] conducted another study on diagnosing 
chest diseases using ANNs. Tuberculosis was also one of the 
diseases considered in this study. They used the previously 
applied LM and BPwM algorithm and extended it for few 
other training algorithms such as Probabilistic Neural 
Network (PNN), Learning Vector Quantization (LVQ) and 
Radical Basis Function (RBF). This study [79], reported the 
LM algorithm obtained the best classification accuracy for 
diagnosis of tuberculosis disease with two hidden layers. 
D. Genetic Algorithm  
Genetic algorithms are search algorithms which work by 
natural selection and natural genetics [80]. Even the simplest 
of GA’s involve three kinds of operators viz, selection, 
crossover, and mutation [81], [82].  Selection operator 
chooses the fittest chromosome for reproduction. Crossover 
operator randomly chooses a point and changes the bits of 
the chromosomes before and after the point to generate new 
offspring’s. Mutation operator randomly changes few of the 
bits in a chromosomes [83]. Fig. 4 represents the flow chart 
of a typical Genetic Algorithm. 
Elveren et al.,[85] used a Multilayer neural network with 
two hidden layers and a Genetic Algorithm (GA) for training 
the algorithm. Reference[85], created a data set of 150 
patient’s samples, which was divided into two classes, one 
class with 50 patients who had TB, another class with 100 
patients who had non-TB diseases. 
84
  
Fig. 4 Genetic algorithm flow chart [84]. 
 
The feature selection for the input layer and estimation of 
the performance of the neural network is similar to[75]. The 
hidden layers consisted of 50 neurons on each layer. One 
single neuron at the output layer, where the output diagnosis 
value 1 represents no TB and 2 represents TB. The results 
obtained showed a classification accuracy of 94.88% in 
predicting the TB cases. The authors compared their results 
with previous studies of [62] and [74], who have reported 
accuracy of 92.30% and  77% respectively. The results of 
[85]  were better than [75], a study on BPwM with two 
hidden layers classification, which reported accuracy of 
93.93%. Reference [85] could not compare their result with 
[75] on Levenberg-Marquardt (LM) algorithm, because of 
the complexity of the algorithm. The authors concluded that 
their classification accuracy for diagnosing TB with GA’s is 
better than previous studies. Training of MLNN with GA 
takes too much time. However, they are also an effective 
way to diagnose TB. 
E. Fuzzy Logic 
The simple framework of the Fuzzy Logic Controller 
(FLC) [86],[87] is shown in Figure 5. The FLC accepts crisp 
input values, which are in the form of degree of Membership 
Function (MF), between 0 and 1. These MFs are described in 
linguistic labels (very cold, cold normal, hot, very hot), it is 
known as fuzzification. The inference engine runs on a set of 
rules. Finally, the rules are defuzzified into crisp output[88]. 
   
Fig. 5 The Fuzzy Logic Controller [89]. 
 
Ansari et al.,[90] used a neuro-fuzzy system to diagnose 
TB. A rule-based fuzzy system, it is an intelligent technique. 
The five inputs were given to the fuzzy inference system, as 
the risk factors to detect TB. The neuro-fuzzy integrated 
system, consist of six layers. It uses the backpropagation 
algorithm that adjusts the membership function and 
optimizes fuzzy rule for each variable. Their proposed model 
gave good results and agreed with the doctor’s opinion [90].  
Omisore et al.,[91] applied the Genetic Neuro Fuzzy 
inferential method for detecting TB. The components of 
their system’s architecture are Knowledge Base, Genetic-
Neuro-Fuzzy Inference System (GENFIS) Engine and 
Decision Support Engine. The database consists of 
structured data (facts and rules for diagnosing TB), 
unstructured data (experience, good practice, guesses, and 
judgments). The GENFIS is comprised of GA, NN, and FL. 
It uses a feed forward propagation learning technique. It is 
created using seven layers of neurons. Only hidden and 
output layers have active nodes and are involved in the 
computation, whereas the nodes at the input are passive. 
Each preceding layer acts as an input to the next layer. 
Fuzzification of the variables is done using triangular 
membership function. It gives output in linguistic terms, 
which describe the severity of the disease. There are twenty-
four diagnostic parameters in the neural network, which are 
divided into five categories. The neural network is trained 
with a back-propagation algorithm with a sigmoid function. 
Genetic Algorithm (GA) use fitness function to obtain the 
optimal value of parameters. The accuracy of the GENFIS 
was reported to be 70% [91]. The low classification accuracy 
is due to insufficient TB patient records. 
F. Artificial Immune System (AIS)  
“AIS is adaptive systems inspired by the biological 
immune system and applied to problem-solving”[92]. When 
a pathogen attacks the immune system, some of the immune 
cells can detect the attack [93]–[95]. As soon as they detect 
the foreign body (antigen), the immune system starts to 
make multiple similar antibodies.  This is called clonal 
expansion.  This expansion produces a large number of 
antibodies, which are specific to the antigen. They either 
neutralize or kill the antigen. These antibodies remember the 
antigens in their immunological memory. So that they can 
respond faster if the same pathogen attacks again [96]. 
Er, et al., [97] used an Artificial Immune System (AIS) 
for diagnosing TB. The authors used their previous dataset 
for the comparative study. Here they applied the AIS 
algorithm for the detection of TB. The classification 
accuracy was reported to be 90%, which is exactly same 
accuracy achieved by using the LM algorithm with two 
hidden layers [97]. 
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Shahaboddin et al, [98] used an Artificial Immune 
Recognition System (AIRS)[99],[100] to diagnose TB. They 
chose twenty features from the 175 medical reports. The 
selected features were classified using both Fuzzy Logic 
Controller (FLC) and the Artificial Immune Recognition 
System (AIRS). They used 10-fold cross-validation. The 
authors reported a 99.14% classification accuracy. 
Saybani et al., in 2015[101] incorporated support vector 
machine (SVM) into AIRS (SAIRS2) to diagnose TB. They 
conducted their study using the dataset from [98]. They used 
a machine learning software called Waikato Environment for 
Knowledge Analysis (WEKA), to develop the SAIRS2 
classifier. To assess the performance of SAIRS2, they 
utilized different built-in algorithms (classifiers) present in 
WEKA for a comparative study on the same TB dataset. To 
validate the performance, they used a 10-fold cross-
validation method. They reported a 100% classification 
accuracy. 
Sayabani et al., in 2016[102]combined Real World 
Tournament Selection (RWTS) with AIRS (RAIRS2) to 
diagnose TB. Tournament Selection (TS) is one of the 
strategical selection method in Genetic Algorithms (GAs) 
[103]. They used the same dataset and performance 
evaluation method as of [101]. A comparative study was 
made on built-in WEKA algorithms and one other study [98]. 
They reported a 100% classification accuracy.  
G. Convolutional Neural Networks 
The field of AI has progressed into a new era of Deep 
Learning. In particular, CNN, which is a class of deep 
learning, which uses a feed-forward artificial neural network 
for analyzing visual imagery. They have become the most 
preferred technique for analyzing medical images. Currently, 
they are considered as state of the art for image classification. 
For the understanding of the CNN, a simple illustration is 
represented below in Fig. 6. 
  
 
Fig. 6 A basic structure of Convolutional Neural Network (CNN)[104]. 
 
CNN consists of many layers, of which few basic are 
mentioned here. Convolutional layer, Pooling layer, and 
Fully-connected (FC) layer. The convolutional layer 
computes a dot product between the small region of the input 
layer and the weights. The pooling layer reduces the spatial 
size of the image, without changing the depth of the image.  
The FC layer as the name implies connects to each neuron of 
one layer to each neuron of another layer.  
Few studies have been carried out for the detection of 
Tuberculosis using the CNN methodology. The main reason 
for the dramatic surge in the use of CNN is due to non-
requirement of the domain knowledge. The CNN model 
extracts and learns meaningful features on its own. It 
segregates the target classes during the training phase. 
Hwang et al.,[105] were the first to propose the 
implementation of CNN for the detection of tuberculosis. 
They modified the AlexNet[106] architecture as per their 
preferences. AlexNet uses general image recognition 
(256x256 size image). In this study, the authors added an 
extra convolutional layer (C1 at the beginning) for feature 
extraction, to support their high-resolution CXR images 
(500x500). The number of hidden nodes in the fully 
connected layer was reduced as less number of training 
images and classes were used. The model was trained with 
two weights: First, with randomized initialized weights and 
second with pretrained convolutional parameters (ImageNet 
classification dataset). The result of applying random 
weights was unsatisfactory with AUC=0.82 & 
Accuracy=0.77. In the case of pretrained weights, the results 
were much better AUC=0.96 & Accuracy=0.90. The 
pretrained model was implemented on the classification of 
the Montgomery and Shenzhen data sets respectively. The 
result obtained in case of Montgomery dataset were 
reasonable with AUC=0.88 & Accuracy=0.67, while in the 
case of Shenzhen dataset the results were impressive with 
AUC=0.93 & Accuracy=0.84. 
Lakhani and Sundaram[107]implemented AlexNet[106] 
and GoogLeNet [107] to classify CXR’s from pulmonary TB 
or as healthy, from four different datasets. These two 
DCNN’s models were divided into pretrained and untrained 
models. The pretrained model was trained using ImageNet. 
All the CXR images were randomly augmented with 
227x227 pixel. The DCNNs, when pretrained on ImageNet 
were named AlexNet-TA and GoogLENet-TA (TA-Trained 
Augmented) and when untrained they were named AlexNet-
UA and GoogLeNet-UA (Untrained augmented). The data 
was divided into training, validation and testing. Accuracies 
of AlexNet-TA=93.3%, GoogLeNet-TA=95.3%, 
Ensemble=96.0% and Radiologist augmented=98.7%.  Out 
of 150 test cases, GoogLeNet-TA and AlexNet-TA were 
able to correctly classify 137 cases trained radiologist 
classified the remaining 13 cases.  
Lopes and Valiati[109] employed three different 
approaches, such as simple feature extraction, Bag of words 
and ensemble using pretrained CNN. Each of the approaches 
utilized all three different architectures (GoogLenet, ResNet 
and VggNet). They implement SVM classifier at the end, to 
detect if the images contain TB or not. The Ensemble 
approach obtained the highest accuracy on the Shenzhen 
dataset. Both simple feature and bag of words in ensemble 
achieved the same accuracy=0.846, whereas the AUCs were 
0.926 & 0.910 respectively. 
Islam et al.,[110] employed CNN's to detect abnormalities 
in the CXRs. They implemented various networks such as 
AlexNet, VGG-16, VGG-19, ResNet-50, ResNet-101, 
ResNet-152 and an ensemble. In their research, the detection 
of TB was carried out as one of the chest abnormalities. 
They have not mentioned the detailed procedure for 
detecting TB. However, they have disclosed the accuracy, 
AUC, sensitivity, and specificity obtained.  
Alcantara et al.,[111] in their research implemented 
GoogLeNet model from the cafe, pre-trained on ImageNet 
for the classification of the CXRs. Their dataset consisted of 
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4701images, which were used for finetuning. The images 
were divided into normal (453 images) and abnormal (4248 
images). For the binary classification, the accuracy was 
89.6%. They considered accuracy to be good, as they did not 
use any pre-processing techniques. The abnormal CXRs had 
various TB manifestation sites. The same method and model 
was executed for multi-class classification. For the multi-
class classification, the abnormal images were categorized 
into four classes. It achieved an accuracy of 62.07%. 
III. RESULTS AND DISCUSSION  
The MLNNs with the LM training algorithm obtained 
better results compared to the BP algorithm. As BP 
algorithm suffers from slow convergence rate, yielding 
suboptimal results. However, the LM algorithm overcomes 
this and converges faster and gives better estimation results, 
noticeable in [75] and [79]. GAs are metaheuristic in nature. 
Concepts of GAs are easy to understand and implement. 
However, MLNNs with GAs is computationally expensive, 
as seen in [85]. FL is helpful in the differential diagnosis of 
the disease and also when a disease has intermediated stages. 
They are suitable in situations describing a nonlinear 
relationship between the input and output states of a system. 
Such as intensity, preciseness, the vagueness of a disease. 
The output results are mentioned linguistically. However, FL 
algorithms are incapable of learning on their own and are 
hardcoded to the defined rules. Therefore, [90] and [91] have 
used FL in differentiating the intensity of the disease using 
linguistic labels. Due to the disadvantage of hard code rules 
in FL. They have combined NN with FL, as NN it gives 
better flexibility in classifying, predicting and pattern 
recognition. AIRS has multiple domain application, and 
decision making in medical diagnosis is one of them. They 
have been proven to be powerful in classification problems, 
resulting in highly accurate models. The accuracy of the 
model directly depends on the parameter or the feature 
selection in cases of manual selection. Therefore, in studies 
such as [98], [101] and [102], 100% accurate results were 
obtained. The methods mentioned above have been effective 
in identifying PTB using mostly clinical symptoms.  
 As technology had advanced and broadened the horizons 
of AI, the focus has dramatically shifted from predictive 
algorithms to CADx systems and deep learning (CNN). This 
is due to the ease; they present in recognition of the images. 
Hence, the application of CNN in the field of medicine 
seems inevitable and promising. In the case of CNN, a 
feature selection of the images is done automatically. 
However, the selection of hyper parameters such as some 
epochs, batch size, activation function, etc, have to be 
defined manually. It is apparent, from the present literature 
that the pre-trained network with transfer learning, along 
with ensemble classification achieved the highest accuracies 
[105],[107] and [110] in case of binary CXR classification. 
However, which was not the case in[109], ensemble 
classifier. 
Table 2 summarises, comparison of datasets, features, 
methods, training algorithm and classification accuracy 
obtained using clinical symptoms and radiological images.  
 
TABLE II 
COMPARISON OF VARIOUS  AI ALGORITHMS USED FOR DIAGNOSING TUBERCULOSIS (TB). 
Author and Year Dataset Features/Par
ameters 
Method Training 
algorithm 
Classification 
accuracy in (%) 
El-Solh et al., 1999 563 patients 21 parameters  GRNN  
(1 hidden layer) 
 92.30 
Santos et al., 2007 136 patient’s medical reports, 
University Hospital, Rio de 
Janeiro, Brazil 
26 clinical 
variables 
MLNN with BP (1 
hidden layer) 
 77.00 
Er, Temurtas et al., 
2010 
150 patient’s medical report, 
Diyarbakir chest Diseases 
Hospital, Turkey. 
38 features 
 
GRNN  
(1 hidden layer) 
 93.18 
MLNN  
(1 hidden layer)  
BPwM 93.04 
LM 93.42 
MLNN  
(2 hidden layers) 
BPwM 93.93 
LM 95.08 
Er, Yumusak & 
Temurtas 2010 
150 patient’s medical report, 
Diyarbakir chest Diseases 
Hospital, Turkey. 
38 features 
 
MLNN  
(1 hidden layer)  
 
BPwM 84.00 
LM 84.00 
 
 
PNN 88.00 
LVQ 84.00 
GRNN 86.00 
RBF 86.00 
MLNN  
(2 hidden layer) 
BPwM 84.00 
LM 90.00 
Elveren & 
Yumusak 2011 
150 patient’s medical report, 
Diyarbakir chest Diseases 
Hospital, Turkey. 
38 features MLNN 
(2 hidden layers) 
Genetic 
Algorithm (GA) 
94.88 
Dongardive et al., 
2011 
250 sample reports,T.B 
Hospitals, Mumbai  
19 features Decision Tree Identification 
Tree (IDT) 
94.50 
Ansari et al., 2012  5 features Neuro-Fuzzy BP 96.00 
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Omisore et al., 
2015 
10 TB patients from St. Francis 
Catholic Hospital.  
(Delta State, Nigeria) 
24 parameters  
 
MLNN  Genetic 
Algorithm + 
Neural Network 
+ Fuzzy Logic 
70.00 
 
Er et al., 2012 50 TB patient’s medical report, 
Diyarbakir chest Diseases 
38 features Artificial Immune 
System(AIS) 
 90.00 
Shahaboddin et al., 
2014 
175 patient medical report from 
Pasteur Laboratory, North Iran 
20 features Fuzzy Logic 
Controller (FLC) with 
Artificial Immune 
Recognition System 
(AIRS) 
 99.14 
Saybani et al., 2015 175 patient medical report from 
Pasteur Laboratory, North Iran 
20 features Support Vector 
Machine (SVM) with 
AIRS 
SAIRS2 100.00 
AIRS2 100.00 
MLP 100.00 
Naïve Bayes 100.00 
J48 100.00 
KNN, K=7 100.00 
RBF classifier 100.00 
Hierarchal LVQ 94.83 
Spegasos 99.82 
Random Forest 99.43 
Ridor 99.43 
Lib Linear 98.33 
Random Tree 98.21 
LVQ with kNN 97.13 
Multi pass LVQ 95.98 
LVQ 94.83 
CLOANALG-
CSCA 
93.68 
CLONALG 92.52 
SMO 89.66 
Zero R 65.49 
Lib SVM 65.49 
Saybani et al., 2016 175 patient medical report from 
Pasteur Laboratory, North Iran 
20 features Real World 
Tournament Selection 
(RTWS) with AIRS 
RAIRS2 100.00 
AIRS2 100.00 
MLP 100.00 
Naïve Bayes 100.00 
J48 100.00 
KNN, K=7 100.00 
RBF classifier 100.00 
HierarchalLVQ 94.83 
Spegasos 99.82 
Random forest 99.43 
Ridor 99.43 
LibLinear 98.33 
Random tree 98.21 
LVQ K-Nearest 
Neighbor 
97.13 
MultipassLVQ 95.98 
LVQ 94.83 
CLOANALG-
CSCA 
93.68 
CLONALG 92.52 
SOM 89.66 
ZeroR 65.49 
LibSVM 65.49 
Hwang et al.,2016 Private Dataset, Montgomery 
County (MC)and Shenzhen 
Datasets 
CXRs CNN 
 
Modified 
AlexNet 
90.00 
Lakhani and 
Sundaram 2017 
Montgomery County (MC), 
Shenzhen, Thomas Jefferson 
University Hospital and Belarus 
Tuberculosis Portal  
CXRs CNN* 
 
Ensemble 96.00 
Radiologist 
augmented  
98.70  
Lopes and Valiati Montgomery County (MC), CXRs CNN*  Ensemble 84.60 
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2017 Shenzhen, 
Islam et al., 2017 Shenzhen Dataset CXRs CNN*  Ensemble 90.00 
Alcantara et al., 
2017 
5,000 CXRs from Partners In 
Health at Peru and various other 
image DB’s 
CXRs CNN Binary 
classification 
89.60 
Multi-class 
classification 
62.07 
 
IV. CONCLUSION  
Many predictive algorithms have been implemented in 
Machine Learning to diagnose Tuberculosis. These 
algorithms have been used to detect and increase the 
accuracy of the models. Different combinations of multilayer 
neural network, decision trees, fuzzy logic, genetic 
algorithms, and artificial immune system have been 
implemented.  
However, there is a specific limitation present in NNs. 
Such as over fitting, at times network, has to be designed by 
trial and error method, they are “Black-Box” in nature, i.e.: 
there is no explanation as to how they work, and at present, 
there is an of lack accurately curated and annotated medical 
image databases.  
Nonetheless, there have been few outstanding research in 
the medical field using CNN. The future work is to use 
CNN's for differential diagnosis. As in the cases of 
tuberculosis, there are various manifestation sites. Therefore, 
multi-class classification, immediate recognition and the 
differentiation of percentage of the disease progress will be 
an immense boon to the medical community.  Deployment 
of the mobile application appears to be cost-effective and 
timesaving. 
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